Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana

Table 1

Prevalence of resistant M. ulcerans isolates in two study districts.

Health centres	Resistant isolates of M. ulcerans
	Rifampicin (40 µg/mL); (%)	Streptomycin (4 µg/mL); (%)	Total; (%)
Asuboi Health Centre	8 (11.4)	2 (2.9)	10 (14.3)
Paakro Health Centre	4 (5.7)	0 (0.0)	4 (5.7)
Total	12 (17.1)	2 (2.9)	14 (20.0)

represents the total M. ulcerans isolates tested; represents the number of resistant M. ulcerans isolates.